• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

依维莫司洗脱支架植入术后的冠状动脉血管运动功能障碍

Coronary vasomotion dysfunction after everolimus-eluting stent implantation.

作者信息

Giudice Pietro, Attisano Tiziana, Di Maio Marco, Bellino Elisabetta M, Polito Maria V, Baldi Cesare, Vigorito Francesco, Di Muro Michele R, Tomasello Salvatore D, Galassi Alfredo R, Piscione Federico

出版信息

Interv Med Appl Sci. 2014 Dec;6(4):178-82. doi: 10.1556/IMAS.6.2014.4.6. Epub 2014 Dec 22.

DOI:10.1556/IMAS.6.2014.4.6
PMID:25598992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4274358/
Abstract

First generation drug-eluting stent can cause a paradoxical "in-segment" coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-eluting stents (EES).

摘要

第一代药物洗脱支架可导致矛盾的“节段内”冠状动脉血管收缩。西罗莫司、紫杉醇以及最近的佐他莫司洗脱支架都出现过这种现象。我们首次描述了一例依维莫司洗脱支架（EES）引起的冠状动脉血管收缩病例。

相似文献

1
Coronary vasomotion dysfunction after everolimus-eluting stent implantation.依维莫司洗脱支架植入术后的冠状动脉血管运动功能障碍
Interv Med Appl Sci. 2014 Dec;6(4):178-82. doi: 10.1556/IMAS.6.2014.4.6. Epub 2014 Dec 22.
2
Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT).腔内可生物降解聚合物生物雷帕霉素洗脱支架与持久性聚合物依维莫司洗脱支架植入术后内皮依赖性和非依赖性血管舒缩反应的比较（COMPARE-IT）。
Int J Cardiol. 2016 Jan 1;202:525-31. doi: 10.1016/j.ijcard.2015.09.085. Epub 2015 Sep 26.
3
Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.药物洗脱支架对内皮依赖性冠状动脉血管舒缩的干扰：与器械相关的反应证据。
Circ Cardiovasc Interv. 2008 Dec;1(3):193-200. doi: 10.1161/CIRCINTERVENTIONS.108.797928.
4
Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.依维莫司和佐他莫司洗脱支架与第一代药物洗脱支架治疗糖尿病患者的疗效和安全性：一项随机试验的荟萃分析
Int J Cardiol. 2017 Mar 1;230:310-318. doi: 10.1016/j.ijcard.2016.12.116. Epub 2016 Dec 27.
5
A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model.在猪冠状动脉模型中比较第三代NOBORI生物雷帕霉素A9洗脱支架与第二代XIENCE V依维莫司洗脱支架的药物洗脱支架生物相容性。
Cardiovasc Revasc Med. 2015 Sep;16(6):351-7. doi: 10.1016/j.carrev.2015.06.009. Epub 2015 Jul 9.
6
Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.生物可吸收聚合物涂层西罗莫司洗脱支架植入术可保留冠状动脉血管运动功能：一项DESSOLVE II试验子研究。
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1141-50. doi: 10.1002/ccd.25610. Epub 2015 Sep 22.
7
Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.在 ST 段抬高型心肌梗死患者中，不同药物洗脱支架或金属裸支架的结局：来自随机试验 34068 患者年随访的试验水平数据的混合治疗比较分析。
Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6.
8
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.无保护左主干冠状动脉疾病中使用佐他莫司洗脱支架与依维莫司洗脱支架的比较。
J Am Coll Cardiol. 2013 Dec 3;62(22):2075-82. doi: 10.1016/j.jacc.2013.07.044. Epub 2013 Aug 21.
9
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响：来自 SPIRIT（依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估）和 COMPARE（真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架）随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.
10
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果：来自 PRODIGY 研究（支架内内膜增生分级后延长双联抗血小板治疗研究）的预先指定分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.

本文引用的文献

1
A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.一位在接受佐他莫司洗脱支架植入术后反复发生灾难性多支血管痉挛的患者。
Korean Circ J. 2013 Jan;43(1):48-53. doi: 10.4070/kcj.2013.43.1.48. Epub 2013 Jan 31.
2
Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.药物洗脱支架对内皮依赖性冠状动脉血管舒缩的干扰：与器械相关的反应证据。
Circ Cardiovasc Interv. 2008 Dec;1(3):193-200. doi: 10.1161/CIRCINTERVENTIONS.108.797928.
3
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.西罗莫司洗脱支架与反常性冠状动脉血管收缩相关。
J Am Coll Cardiol. 2005 Jul 19;46(2):231-6. doi: 10.1016/j.jacc.2005.01.062.
4
Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation.紫杉醇支架植入术后迟发性严重多支血管痉挛与猝死未遂
Heart. 2005 Feb;91(2):e15. doi: 10.1136/hrt.2004.049932.
5
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.β2肾上腺素能受体在人类动脉粥样硬化性冠状动脉中的作用。
Circulation. 2005 Jan 25;111(3):288-94. doi: 10.1161/01.CIR.0000153270.25541.72. Epub 2005 Jan 10.